Logo

Abbott

Abbott Q2 Diagnostics Revenues Rise 63 Percent on COVID-19 Testing Demand

The firm said that excluding COVID-19 testing sales, its worldwide diagnostics sales increased 42.5 percent on a reported basis in the second quarter.

Abbott's Alere Paying $38.8M to Settle False Claims Allegations

Alere and Alere San Diego were accused of knowingly selling defective blood coagulation monitors to Medicare patients taking anticoagulant drugs.

Abbott Panbio COVID-19 Rapid Antigen Self-Test Receives CE Mark for DTC Use

The lateral flow test doesn't require an instrument and can be used in symptomatic or asymptomatic adults and children.

Spurred on by COVID-19 Pandemic, Laboratories Accelerate Automation Efforts
Premium

Laboratories of all kinds are automating their workflows, particularly those involving sample prep and other preanalytical steps. 

Abbott Lowers FY21 Guidance as It Sees Sharp Decline in COVID-19 Test Revenue

The firm's CEO said that despite the decline, its base business is returning to normal and has "strong momentum."

May 10, 2021

Abbott Donates 450K Rapid Diagnostic Tests for Sleeping Sickness to FIND

Apr 21, 2021

Following EUA for OTC SARS-CoV-2 Antigen Test, Abbott Looks at Rapid Testing as Key Growth Driver
Premium

Apr 20, 2021

Abbott Q1 Diagnostics Revenues More Than Double on COVID-19 Testing

Apr 2, 2021

Abbott Focuses on Future Pandemic Preparedness With New Global Diagnostics Coalition
Premium

Apr 1, 2021

Flush With $10B From Biden Administration, SARS-CoV-2 Testing in K-12 Schools Poised to Escalate
Premium

Apr 1, 2021

FDA Authorizes Quidel, Abbott, BD Coronavirus Antigen Tests for Serial Testing

Mar 18, 2021

Abbott Receives $255M Contract from DoD to Supply SARS-CoV-2 Antigen Tests

Mar 11, 2021

Abbott Forms Global Coalition to Monitor, Prevent Future Pandemics

Mar 5, 2021

Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

Mar 5, 2021

Dx Developers Hedge on SARS-Cov-2 Rapid Antigen Tests, Citing Conflicting FDA Messages
Premium

Mar 4, 2021

In Brief This Week: Abbott Laboratories, LexaGene, Caris Life Sciences, SQI Diagnostics, and More

Mar 3, 2021

Abbott SARS-CoV-2 IgG Antibody Test Receives Emergency Use Authorization from FDA

Feb 18, 2021

WHO Finds High Diagnostic Accuracy in Three Classes of MDx Technologies for TB Testing, Resistance

Feb 17, 2021

At Tri-Con, Harvard's Michael Mina Backs Antigen-Based Screening to Stem SARS-CoV-2
Premium

Feb 8, 2021

Siemens Healthineers, Roche, Abbott Receive FDA 510(k) Clearances in January

Jan 27, 2021

BrainBox Solutions Entering Pivotal Clinical Study for Multimarker Concussion Test
Premium

Jan 27, 2021

Abbott Continuing Focus on Rapid Testing in Light of COVID-19 Pandemic
Premium

Jan 27, 2021

Abbott Q4 Diagnostics Revenues up 111 Percent, FY20 Revenues up 9 Percent

Jan 26, 2021

Abbott Panbio SARS-CoV-2 Rapid Antigen Test Nabs CE Mark for Asymptomatic Screening, Self-Collection

Jan 19, 2021

CDC Study Finds Abbott BinaxNow SARS-CoV-2 Antigen Test Less Sensitive Than PCR, But Still Useful